Both in Surgical Instruments
Boston Scientific vs DexCom
Over the past year BSX returned −54.5% and DXCM returned +30.4%; their daily moves had a correlation of 0.25.
BSX −54.5% DXCM +30.4%Growth of $1, one year, split-adjusted
| Metric | BSX | DXCM |
|---|---|---|
| Price | $44.11 | $86.68 |
| Market cap | $63.93B | $32.71B |
| Today | +0.43% | +0.07% |
| 1 month | −5.5% | −2.9% |
| 6 months | −36.2% | +39.2% |
| Year to date | −53.7% | +30.6% |
| 1 year | −55.1% | +26.9% |
| Revenue growth (YoY) | +7.5% | +13.1% |
| Gross margin | 70.7% | 63.4% |
| Net margin | 16.7% | 19.0% |
| P/E (TTM) | 17.4× | 32.7× |
| Price / sales | 3.0× | 6.6× |
| Net cash | -$12.09B | $704.2M |
| Dividend yield | — | — |
| Volatility (60d) | 35.3% | 39.6% |
| Short % of float | 3.2% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).